Targeting replication stress response using polypurine reverse hoogsteen hairpins directed against WEE1 and CHK1 genes in human cancer cells
Related Experiment Video
Updated: Dec 26, 2025

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
Published on: February 10, 2023
Eva Aubets1, Véronique Noé1, Carlos J Ciudad1
1Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences and Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona (UB), 08028 Barcelona, Spain.
Abstract:
In response to DNA damage, cell cycle checkpoints produce cell cycle arrest to repair and maintain genomic integrity. Due to the high rates of replication and genetic abnormalities, cancer cells are dependent on replication stress response (RSR) and inhibitors of this pathway are being studied as an anticancer approach. In this direction, we investigated the inhibition of CHK1 and WEE1, key components of RSR, using Polypurine Reverse Hoogsteen hairpins (PPRHs) as gene silencing tool. PPRHs designed against WEE1 or CHK1 reduced the viability of different cancer cell lines and showed an increase of apoptosis in HeLa cells. The effect of the PPRHs on cell viability were dose- and time-dependent in HeLa cells. Both the levels of mRNA and protein for each gene were decreased after treatment with the PPRHs. When analyzing the levels of the two CHK1 mRNA splicing variants, CHK1 and CHK1-S, there was a proportional decrease of the two forms, thus maintaining the same expression ratio. PPRHs targeting WEE1 and CHK1 also proved to disrupt cell cycle after 15 h of treatment. Moreover, PPRHs showed a synergy effect when combined with DNA damaging agents, such as methotrexate or 5-Fluorouracil, widely used in clinical practice. This work validates in vitro the usage of PPRHs as a silencing tool against the RSR genes WEE1 and CHK1 and corroborates the potential of inhibiting these targets as a single agent therapy or in combination with other chemotherapy agents in cancer research.
Insights
Polypurine Reverse Hoogsteen hairpins (PPRHs) effectively silenced WEE1 and CHK1 genes, crucial for cancer cell survival. This inhibition reduced cancer cell viability and enhanced apoptosis, showing promise as an anticancer strategy.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Silencing
Background:
- Cell cycle checkpoints are vital for repairing DNA damage and maintaining genomic integrity.
- Cancer cells, with high replication rates and genetic instability, rely on the replication stress response (RSR).
- Inhibiting RSR pathways presents a potential anticancer therapeutic strategy.
Purpose of the Study:
- To investigate the efficacy of Polypurine Reverse Hoogsteen hairpins (PPRHs) in silencing WEE1 and CHK1, key RSR components.
- To evaluate PPRHs as a potential gene-silencing tool for cancer therapy.
- To assess the synergistic effects of PPRHs with existing chemotherapeutic agents.
Main Methods:
- Designing and utilizing PPRHs to target WEE1 and CHK1 genes for silencing.
- Assessing the impact of PPRHs on cancer cell viability, apoptosis, and cell cycle progression in vitro.
- Quantifying changes in WEE1 and CHK1 mRNA and protein levels post-PPRH treatment.
- Evaluating the combined effects of PPRHs with DNA damaging agents like methotrexate and 5-Fluorouracil.
Main Results:
- PPRHs targeting WEE1 or CHK1 significantly reduced the viability of various cancer cell lines.
- Apoptosis increased in HeLa cells treated with PPRHs.
- PPRH treatment led to dose- and time-dependent reductions in WEE1 and CHK1 mRNA and protein levels.
- PPRHs disrupted the cell cycle and demonstrated synergistic effects when combined with methotrexate or 5-Fluorouracil.
Conclusions:
- PPRHs are validated as an effective in vitro gene-silencing tool against RSR genes WEE1 and CHK1.
- Inhibiting WEE1 and CHK1 holds potential as a monotherapy or combination therapy for cancer treatment.
- PPRHs show promise for enhancing the efficacy of conventional chemotherapy agents.
Related Concept Videos
The DNA Replication Fork
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
DNA Helicases
Homologous Recombination

